Dori Bilik

480 total citations
8 papers, 402 citations indexed

About

Dori Bilik is a scholar working on Endocrinology, Diabetes and Metabolism, General Health Professions and Molecular Biology. According to data from OpenAlex, Dori Bilik has authored 8 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Endocrinology, Diabetes and Metabolism, 3 papers in General Health Professions and 2 papers in Molecular Biology. Recurrent topics in Dori Bilik's work include Diabetes Treatment and Management (3 papers), Primary Care and Health Outcomes (2 papers) and Chronic Disease Management Strategies (2 papers). Dori Bilik is often cited by papers focused on Diabetes Treatment and Management (3 papers), Primary Care and Health Outcomes (2 papers) and Chronic Disease Management Strategies (2 papers). Dori Bilik collaborates with scholars based in United States. Dori Bilik's co-authors include William H. Herman, Morton B. Brown, Ronald T. Ackermann, Jesse C. Crosson, Laura N. McEwen, Susan L. Ettner, Ping Zhang, Ping Zhang, Rui Li and Andrew J. Karter and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Journal of General Internal Medicine.

In The Last Decade

Dori Bilik

8 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dori Bilik United States 7 209 89 82 73 67 8 402
Shyi-Jang Shin Taiwan 11 139 0.7× 88 1.0× 31 0.4× 31 0.4× 44 0.7× 13 368
Nicole Yurgin United States 15 370 1.8× 79 0.9× 158 1.9× 137 1.9× 96 1.4× 33 720
James C. Capretta United States 4 180 0.9× 140 1.6× 36 0.4× 59 0.8× 37 0.6× 9 427
Anna Glechner Austria 10 117 0.6× 66 0.7× 33 0.4× 53 0.7× 24 0.4× 23 402
Pierre Johansen Denmark 15 396 1.9× 140 1.6× 68 0.8× 92 1.3× 162 2.4× 43 543
Steven H. Hendriks Netherlands 14 125 0.6× 85 1.0× 26 0.3× 51 0.7× 30 0.4× 25 338
Nasrin Mansournia Iran 12 152 0.7× 94 1.1× 43 0.5× 48 0.7× 31 0.5× 28 480
Calvin Ke Canada 11 364 1.7× 95 1.1× 22 0.3× 86 1.2× 86 1.3× 33 573
Jedidiah I Morton Australia 12 268 1.3× 62 0.7× 67 0.8× 116 1.6× 39 0.6× 58 460
Andreas Liebl Germany 10 426 2.0× 64 0.7× 24 0.3× 93 1.3× 121 1.8× 17 509

Countries citing papers authored by Dori Bilik

Since Specialization
Citations

This map shows the geographic impact of Dori Bilik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dori Bilik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dori Bilik more than expected).

Fields of papers citing papers by Dori Bilik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dori Bilik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dori Bilik. The network helps show where Dori Bilik may publish in the future.

Co-authorship network of co-authors of Dori Bilik

This figure shows the co-authorship network connecting the top 25 collaborators of Dori Bilik. A scholar is included among the top collaborators of Dori Bilik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dori Bilik. Dori Bilik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Li, Rui, Dori Bilik, Morton B. Brown, et al.. (2013). Medical costs associated with type 2 diabetes complications and comorbidities.. PubMed. 19(5). 421–30. 122 indexed citations
2.
Zhang, Ping, et al.. (2012). Health Utility Scores for People With Type 2 Diabetes in U.S. Managed Care Health Plans. Diabetes Care. 35(11). 2250–2256. 90 indexed citations
3.
McEwen, Laura N., et al.. (2010). The Cost, Quality of Life Impact, and Cost–Utility of Bariatric Surgery in a Managed Care Population. Obesity Surgery. 20(7). 919–928. 43 indexed citations
4.
Bilik, Dori, Laura N. McEwen, Morton B. Brown, et al.. (2010). Thiazolidinediones and Fractures: Evidence from Translating Research into Action for Diabetes. The Journal of Clinical Endocrinology & Metabolism. 95(10). 4560–4565. 64 indexed citations
5.
Duru, O. Kenrik, Dori Bilik, Laura N. McEwen, et al.. (2010). Primary Language, Income and the Intensification of Anti-glycemic Medications in Managed Care: the (TRIAD) Study. Journal of General Internal Medicine. 26(5). 505–511. 6 indexed citations
6.
Bilik, Dori, Laura N. McEwen, Morton B. Brown, et al.. (2010). Thiazolidinediones, cardiovascular disease and cardiovascular mortality: translating research into action for diabetes (TRIAD). Pharmacoepidemiology and Drug Safety. 19(7). 715–721. 12 indexed citations
7.
Kim, Catherine, Edward F. Tierney, William H. Herman, et al.. (2009). Physician perception of reimbursement for outpatient procedures among managed care patients with diabetes mellitus.. PubMed. 15(1). 32–8. 2 indexed citations
8.
McEwen, Laura N., Dori Bilik, Susan L. Johnson, et al.. (2009). Predictors and Impact of Intensification of Antihyperglycemic Therapy in Type 2 Diabetes. Diabetes Care. 32(6). 971–976. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026